Celaid Therapeutics will participate in the 2025 Cell & Gene Meeting on the Mesa (#CGMesa25), held on October 6–8, 2025, in Phoenix, Arizona.
Organized by the Alliance for Regenerative Medicine, this leading international conference brings together experts in cell and gene therapy to discuss cutting-edge science, regulatory trends, and business opportunities.
Through the partnering program, we will actively explore collaboration opportunities and look forward to introducing our innovative hematopoietic stem cell (HSC) technology and our therapeutic candidate CLD-001.
If you are interested in our HSC platform or pipeline, please connect with us through the partnering system or contact us directly.